StatLab Medical Opens New Injection Molding Facility

The 35,000-square-foot facility is located in Arlington, Texas.

Stat Lab Arlington Cassette Production
StatLab Medical

StatLab Medical Products (StatLab), a global developer and manufacturer of medical diagnostic equipment and supplies, announces the commencement of injection molding manufacturing at a new, state-of the-art histology consumable manufacturing facility in Arlington, Texas.

Injection molding at this new 35,000 square foot facility—with room for future expansion—will give laboratories the confidence of additional core histology consumables produced by StatLab in the United States. The addition of the Arlington plant expands the StatLab in-house manufacturing network to a total of 6 locations across the United States, United Kingdom, and Germany, making the supply chain shorter, more reliable, and more effective. Onsite injection molding capabilities support not only histology cassette manufacturing but also additional components and packaging materials to further reduce the carbon footprint of products, reduce costs and empower more value for customers while offering more control over the product development ecosystem and supply chain. The successful acquisition of Wales-based CellPath Ltd. in 2022, well-known for injection molding manufacturing of histology supplies, served as a catalyst for this significant capability expansion. Other planned capability expansions at the Arlington, Texas site include blow molding as well as glass slide manufacturing.

The launch of new histology manufacturing capabilities at StatLab offers the flexibility to meet market needs while expanding the StatLab portfolio of manufactured cassettes to include a wide variety of styles compatible not only with the PiSmart printer, but also with other on-market printers as well as for manual use.

More in Equipment